We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes / R. Lombardi, L. Airaghi, G. Targher, G. Serviddio, G. Maffi, A. Mantovani, C. Maffeis, A. Colecchia, R. Villani, L. Rinaldi, E. Orsi, G. Pisano, L.E. Adinolfi, S. Fargion, A.L. Fracanzani. - In: JOURNAL OF DIABETES AND ITS COMPLICATIONS. - ISSN 1056-8727. - 34:11(2020), pp. 107684.1-107684.3. [10.1016/j.jdiacomp.2020.107684]
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes
R. Lombardi;R. Villani;L. Rinaldi;E. Orsi;S. Fargion;A.L. Fracanzani
2020
Abstract
We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1056872720304463-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
269.64 kB
Formato
Adobe PDF
|
269.64 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.